Nemera Announces Better Drug Deposition with RetroNose

nemera020519.jpg

After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is presenting enhanced drug deposition results compared to classic nasal sprays with RetroNose.

 ALREADY REGISTERED USER? SIGN IN now

 

REGISTER FOR FREE TO CONTINUE READING THIS ARTICLE

And get access to unlimited world-class packaging reporting and commentary.